Affiliation:
1. Medical Academy, Kabardino-Balkarian State University named after H. M. Berbekov
Abstract
A study of interleukin-1β, interleukin-10, and CD40 ligand (CD40L) parameters in patients with arterial hypertension (AH), coronary heart disease (CHD), including cardiac arrhythmias (CA), was carried out. The study included 90 patients, divided into 3 groups (AH, CHD, CHD + CA). The results of the study demonstrated the possible involvement of an inflammatory cytokine, interleukin-1, in the development of AH, the level of which in our study significantly increased with the addition of such cardiovascular complications as heart failure (HF), CHD, including CHD with CA.
Reference13 articles.
1. Adawi A., Zhang Y., Baggs R. et al. Disruption of the CD40–CD40l system prevents an oxygeninduced distress syndrome. Am J Pathol. 1998; 152 (3): 651–657.
2. Amir O., Rogowski O., David M. et al. Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha. Isr Med Assoc J. 2010; 12(3): 158–162.
3. Miettinen K.H., Lassus J., Harjola V.P. et al. Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail. 2008; 10 (4): 396–403. doi: 10.1016/j.ejheart.2008.02.008.
4. Myrianthefs P.M., Lazaris N., Venetsanou K. et al. Immune status evaluation of patients with chronic heart failure. Cytokine. 2007; 37 (2): 150–154. doi: 10.1016/j.cyto.2007.03.007.
5. Oikonomou E., Tousoulis D., Siasos G. et al. The role of inflammation in heart failure: new therapeutic approaches. Hellenic J Cardiol. 2011; 52 (1): 30–40.